RT Journal Article
SR Electronic
T1 Association of national Bacille Calmette-Guérin vaccination policy with COVID-19 epidemiology: an ecological study in 78 countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20100156
DO 10.1101/2020.05.13.20100156
A1 Kuratani, Norifumi
YR 2020
UL http://medrxiv.org/content/early/2020/05/16/2020.05.13.20100156.abstract
AB A possible association between national Bacille Calmette-Guérin (BCG) vaccination policy and lower COVID-19 incidence has been suggested in some preprint papers. Using publicly accessible databases, I explored associations of national BCG vaccination policy with COVID-19 epidemiology in 78 countries. Data collection was conducted from April 25 to May 5, 2020. I compared countries that have a current universal BCG vaccination policy (BCG countries), with countries that currently lack such a policy (non-BCG countries). The mixed effect model revealed national BCG policy decreases in the country-specific risk of death by COVID-19, correspond to odds ratio of 0.446 (95% confidence interval 0.323 - 0.614, P=1×10−5). In BCG countries, the case increase rate was attenuated marginally by 25.4% (95% confidence interval 3.0 to 42.7, P=0.029) as compared with those of the non-BCG countries. Although the protective mechanism of BCG vaccination against COVID-19 remains unknown, further laboratory and clinical research should be warranted.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study is secondary data analysis using publicly accessible databases.Funding StatementThis study was supported by the institutional resource.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were extracted from publicly accessible databases. The sources of databases were shown in the references.